ForumIAS LATEST
- 16 June | Failed Before Success: AIR 295 Reveals His UPSC Journey | Click Here to Watch →
- 17 June | How to Write High-Scoring Answers in Hindi Literature Optional | Click Here to Watch →
- 18 June | From Setback to Success: Bhavika Chopra's Rise to AIR 25 | Click Here to Watch →
- 19 June | The Rankforge Challenge (FRC/Tapasya): Truth About UPSC & Coaching by Ayush Sinha | Click Here to Watch →
- 20 June | 150+ Cleared UPSC Prelims from Naugaon, Alwar | The FRC Tapasya Success Story | Click Here to Watch →
- The World Health Organisation (WHO) has recommended the use of the HIV drug dolutegravir(DTG) as the preferred first-line and second-line treatment for all populations.
- This drug can also be used for patients including pregnant women and those of childbearing potential.
- Dolutegravir(DTG) which is sold under the brand name Tivicay is an antiretroviral medication used together with other medication to treat HIV/AIDS.
- Studies have shown that DTG is more effective,easier to take and has fewer side effects than alternative drugs.It also has a high genetic barrier to developing drug resistance which is important given the rising trend of resistance.
- In 2019,82 low- and middle-income countries reported to be transitioning to DTG-based HIV treatment.The new recommendations aim at helping more nations improve their HIV policies.
- HIV stands for human immunodeficiency virus. It is the virus that can lead to acquired immunodeficiency syndrome (AIDS), if not treated. There are two main types of the virus: HIV-1 and HIV-2. HIV-2.
- At present there is no effective cure for HIV but HIV can be controlled. The medicine used to treat HIV is called antiretroviral therapy or ART.
